APA (7th ed.) Citation

Cheng, N., Dominguez, A., Manthena, S. R., & Shah, D. (2026). Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims Analysis. Neurology & Therapy, 1. https://doi.org/10.1007/s40120-026-00967-3

Chicago Style (17th ed.) Citation

Cheng, Ning, Annaliza Dominguez, Shivaji R. Manthena, and Darshini Shah. "Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims Analysis." Neurology & Therapy 2026: 1. https://doi.org/10.1007/s40120-026-00967-3.

MLA (9th ed.) Citation

Cheng, Ning, et al. "Real-World Treatment Switch Rates, and Healthcare Costs of Botulinum Toxin Type A Among Patients with Cervical Dystonia in the USA: A Retrospective Claims Analysis." Neurology & Therapy, 2026, p. 1, https://doi.org/10.1007/s40120-026-00967-3.